Abstract 3090: The MAT2A inhibitor, AG-270, combines with both taxanes and gemcitabine to yield enhanced anti-tumor activity in patient-derived xenograft models
Hyer, Marc L., Kalev, Peter, Fletcher, Mark, Chen, Chi-Chao, Aguado-Fraile, Elia, Mandley, Everton, Newhouse, Sheila, Lein, Max, Nagaraja, Raj, Tuncay, Yesim, Murtie, Josh, Marks, Kevin M., Marjon, Katya
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract PR10: IK-595, a MEK-RAF complex inhibitor, obviates CRAF mediated resistance resulting in superior RAS/MAPK pathway inhibition and anti-tumor activity in RAS/RAF altered cancers
Haines, Eric, Burke, Michael, Catterall, Rachel, De Jesus, Victor, Li, Bin, Manna, Joseph D., Punkosdy, George, Zavidij, Oksana, Wessel, Sarah R., Werosta, Grace, Cavanaugh, Jill, Newhouse, Sheila, Basavapathruni, Aravind, Xu, Lan, Santillana, Sergio, Zhang, X. Michelle, Ruppel, Sabine K.
Published in Molecular cancer research (01.05.2023)
Published in Molecular cancer research (01.05.2023)
Get full text
Journal Article